✦ LIBER ✦

Biochemotherapy for melanoma

✍ Scribed by Philip Agop Philip; Lawrence E. Flaherty

Book ID: 107545952
Publisher: Current Science Inc.
Year: 2000
Tongue: English
Weight: 393 KB
Volume: 2
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-000-0024-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemotherapy for advanced melanoma

✍ Ulrich Keilholz; Martin E. Gore 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Biochemotherapy of melanoma

✍ Lawrence E Flaherty; Shirish M Gadgeel 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Biochemotherapy for melanoma : Rational

Biochemotherapy for melanoma : Rational therapeutics in the search for weapons of melanoma destruction

✍ Kim A. Margolin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Understanding of the mechanisms underlying the activity and limitations of biochemotherapy remains inadequate. The design of new regimens should based on emerging knowledge regarding molecular mechanisms of oncogenesis, cancer cell proliferation and survival, and control apoptosis. See also pages 5

349 Chemo versus biochemotherapy in meta

349 Chemo versus biochemotherapy in metastatic melanoma

✍ M. Middleton 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Chemotherapy vs biochemotherapy QOL effe

Chemotherapy vs biochemotherapy QOL effect in melanoma

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Pilot study of high-dose, concurrent bio

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma

✍ Kevin B. Kim; Omar Eton; Mary Jo East; Cynthia Hodges; Nicholas E. Papadopoulos; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Background: Durable complete response rates ranging from 5% to 20% have been reported in association with biochemotherapy for patients with metastatic melanoma, with response rates on the low end of this range being observed in trials that used lower doses and less intense treatment schedules. i